Meningitis is a serious central nervous system-infective disease caused mainly by pathogens such as bacteria, viruses and fungi. The following are medications for meningitis:
i. Antibacterial treatment (for bacterial meningitis) Empirical antibacterial treatment should begin as soon as possible when bacterial meningitis is suspected, as delays in treatment can lead to serious neurological after-effects and even death. For adult patients, anti-bacterial drugs that can pass through the blood-brain barrier, such as third-generation cystasy (e.g., twilight, twilight) are usually selected. These drugs have good anti-bacterial activity for bacteria that often cause meningitis, such as pneumocococcal and meningitis naser. If the possibility of a drug-resistant infection is considered, e.g., meningitis caused by methoxysilin-yellen fungus (MRSA), the use of vancomicin may be required. In the case of children, the choice of medicines is also based on possible pathogens and drug safety. For example, for infants and children over three months old, twilight or twilight is a common first-line drug. • Drug dosage and course of treatment: The dose of antibacterial drugs usually needs to be adjusted to the age, weight, kidney function of the patient. For example, the daily dosage of croquetone used for bacterial meningitis in adults is typically 2 – 4 g, with 1 – 2 intravenous drips; for children, the dosage is typically 100 mg/kg per day, with 1 – 2 doses. The treatment process is usually long, typically 10 – 14 days, and may require longer treatment for complex or difficult cases. Throughout the treatment, the patient ‘ s symptoms, signs and the results of the brain vertebrate test are closely monitored to determine the effectiveness of the treatment.
Antiviral treatment (for viral meningitis) For viral meningitis, there are currently no treatments that are as effective and widely used as anti-bacterial drugs. However, for some specific viruses, there are options for antiviral drugs. For example, Azurowe is the drug of choice for meningitis caused by herpes-only viruses. It can inhibit the synthesis of the virus’s DNA, thus preventing its replication. Usage is usually 10 mg/kg per hour, once every 8 hours, and IV drops, usually for 14 – 21 days. Meningitis caused by the herpes virus can also be treated in Azurowe. • Other support treatments are combined with anti-viral drugs: treatment of viral meningitis with anti-viral drugs usually needs to be combined with other support treatments, such as heat control and reduction of internal pressure. Because viral meningitis relies mainly on the patient ‘ s own immune system to clean up the virus, antiviral drugs are more of a supporting effect in mitigating the virus ‘ s damage to the nervous system.
iii. Anti-foul medicine (for fungal meningitis) Fungial meningitis is relatively rare, but it is common among people with low immune functions, such as people living with AIDS, chronically using immunosuppressants, etc. The drugs used to treat fungal meningitis are mainly pepcin B, fluoride, Ecraconol, etc. Pycin B is a broad spectrum antifluent drug with a high level of antibacterial activity for various fungi, but it is more toxic, especially for kidneys. Indicators such as kidney function need to be closely monitored when used. Fluconium is relatively less toxic and has a relatively good effect on meningitis caused by pyrocolosis. • Consideration of the way in which drugs are given and the course of treatment: Pycin B is typically injected through intravenous drips, and because of its side effects, other drugs are usually used jointly to mitigate the toxic effects. Fluorine can be oral or intravenous, and the specific doses and treatments are determined on the basis of fungi type, patient response etc. The treatment of fungal meningitis is usually long and may take months, during which time there is a regular vertebrate test to see if fungi have been removed.
iv) The use of intracranial pressure medications: Meningococcal pressure rises often in cases of meningitis, leading to severe symptoms such as headaches, vomiting, cognitive disorders and even life-threatening complications such as encephalus. Condensine is a common intracranial pressure reduction drug and is a highly permeable dehydration agent. In general, the dose is rapidly dripping through the veins, depending on the body weight of the patient and the internal pressure of the skull, e.g., the dose used in adults is 125 – 250 ml per dose per 4 – 6 hours. In the use of glyphol, care is taken to monitor the kidney function and electrolyte of the patient, as it may cause electrolytic disorders and kidney damage. • Application of glycerine nut sugar: Glycerine sugar is also a drug that reduces internal pressure in the skull, and its effect is relatively moderate and long. It can be used interchangeably with glyphol, reducing its use and thus reducing the risk of associated side effects. Glycerine nut sugars are generally intravenous dripping and dosages are adapted to the patient ‘ s condition. In the course of the treatment of meningitis, in addition to measures such as treatment of pathogens and reduction of intracranial pressure, attention needs to be paid to the overall condition of the patient, such as maintenance of water, electrolyte balance and nutritional security, in order to improve his or her chances of recovery.
